1.National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (2002) USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, pp. 205–212. Bethesda, MD: NIH.
2.Van Wyck, DB (1989) Iron management during recombinant human erythropoietin therapy. Am J Kidney Dis 14, 9–13.
3.Tamg, DC, Chen, TW & Huang, TP (1995) Iron metabolism indices for early prediction of the response hemodialysis patients. Am J Nephrol 15, 230–237.
4.Kleiner, MJ, Van Wyck, DB, Kaupke, CJ & Kirlin, LF (1995) The role of iron and other factors in patients unresponsive to erythropoietin therapy. Semin Dial 8, 29–34.
5.Silverberg, DS, Blum, M, Peer, G, Kaplan, E & Aiana, A (1996) Intravenous ferric saccharate as an iron supplement in dialysis patients. Nephron 72, 413–417.
6.Ebert, BL & Bunn, HF (1999) Regulation of erythropoietin gene. Blood 94, 1864–1877.
7.Charytan, C, Levin, N, Al-Saloum, M, Hafeez, T, Gagnon, S & Van Wyck, DB (2001) Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anaemia: North American clinical trial. Am J Kidney Dis 37, 300–307.
8.Nissenson, AR, Lindsay, RM, Swan, S, Seligman, P & Strobos, J (1999) Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American clinical trial. Am J Kidney Dis 33, 471–482.
9.National Kidney Foundation (2001) K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease, 2000. Am J Kidney Dis 37, S182–S238.
10.Van Wyck, DB, Cavallo, G, Spinowitz B, S, Adhikarla, R, Gagnon, S, Charytan, C & Levin, N (2000) Safety and efficacy of iron sucrose in patients sensitive to iron dextran. Am J Kidney Dis 36, 88–97.
11.Kalantar-Zadeh, K, McAllister, CJ, Lehn, RS, Liu, E & Kopple, JD (2004) A low serum iron level is a predictor of poor outcome in hemodialysis patients. Am J Kidney Dis 43, 671–684.
12.Macdougall, IC, Chandler, G, Elston, O & Harchowal, J (1999) Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit. Am J Kidney Dis 34, S40–S46.
13.Silva, J, Andrade, S, Ventura, H, Santos, JP, Colaco, S, Oliveira, C & Ponce, P (1998) Iron supplementation in hemodialysis – practical clinical guideline. NTD 13, 2572–2577.
14.Besarab, A, Frinak, S & Yee, J (1999) An indistinct balance: the safety and efficacy of parenteral iron therapy. J Am Soc Nephrol 10, 2029–2043.
15.Aronoff, GR, Bennett, WM, Blumenthal, S et al. (2004) Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens. Kidney Int 66, 1193–1198.
16.Fishbane, S (2003) Safety in iron management. Am J Kidney Dis 41, 18–26.
17.Yee, J & Besarab, A (2002) Iron sucrose: the oldest iron therapy becomes new. Am J Kidney Dis 40, 1111–1121.